|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.285 CAD | -.--% |
|
-.--% | +29.55% |
| 05-17 | NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 05-16 | Charles Burns Tenders Resignation as Director of NexgenRx Inc | CI |
NexgenRx Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was CAD 4.29 million compared to CAD 3.46 million a year ago. Net income was CAD 0.460949 million compared to CAD 0.194927 million a year ago.
Basic earnings per share from continuing operations was CAD 0.006 compared to CAD 0.003 a year ago. Diluted earnings per share from continuing operations was CAD 0.006 compared to CAD 0.003 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +29.55% | 14.82M | |
| -4.90% | 115B | |
| +9.16% | 101B | |
| +11.67% | 67.41B | |
| +24.65% | 66.1B | |
| +14.52% | 44.58B | |
| +14.85% | 43.37B | |
| +18.26% | 35.13B | |
| +9.42% | 26.31B | |
| -2.41% | 22.77B |
NEXGENRX INC. 
